Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease.

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

BACKGROUND: Research indicates that patients undergoing bariatric surgery face a six to seven times higher risk of developing alcohol use disorder (AUD) compared with the population of obese ...

Medically reviewed by Jay N. Yepuri, MD FibroScan is the brand name for transient elastography, an abdominal ultrasound that ...

Alcohol use disorder (AUD) is a major global public health issue, affecting more than 28 million adults in the United States ...

A phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving with low-dose semaglutide. HealthDay News — Low-dose semaglutide seems to reduce craving and certain ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

As health complications and deaths from alcohol use disorder (AUD) increase in the United States, it is critical that people ...

Minnesota law enforcement officers tried out two devices that can detect six classes of drugs and chemicals that can impair ...

Those tests – the Abbott SoToxa™ Oral Fluid Mobile Test System and the Dräger DrugTest 5000 – test for recent use of six drug ...

A blood glucose test measures how much sugar you have in your blood. You may have a blood glucose test in a doctor’s office, laboratory, or with a fingerstick meter at home. When you eat ...